Breaking News on Contract Research, Manufacturing & Clinical Trials

Hot Topics > Consolidation

Medpace joins list of CROs attracting private equity investment

24-May-2011 - New York-headquartered private equity investment group CCMP Capital will buy a majority stake in US CRO Medpace.

PRA International acquires key software developer; expands eClinical solutions

23-May-2011 - US contract research organisation (CRO) PRA International claims it intends to “reshape how the industry manages trials” after acquiring Indian eClinical software developer, Kinship Technologies, for an undisclosed amount.

inVentiv to buy PharmaNet as CRO consolidation continues

18-May-2011 - inVentiv Health is to make PharmaNet its second CRO acquisition of the year as it aims to compete for strategic alliances.

Clinipace buys PFC to further global expansion plan

18-May-2011 - Clinipace has made PFC Pharma Focus its third acquisition in 18 months and is planning more takeovers to expand geographic reach.

INC Research to buy Kendle & aim at top 5 clinical CROs

05-May-2011 - INC Research is to acquire Kendle in a deal that would give it Phase II to IV clinical assets comparable to those at Covance.

Exclusive interview

CIT chairman discusses LAB takeover

05-May-2011 - Last week non-clinical CRO CIT bought Canadian counterpart LAB Research. spoke with CIT executive chairman Jean-Francois Le Bigot about the deal and the plan going forward.

Private equity CRO buying spree set to continue

03-May-2011 - Private equity firms have snapped up CROs over the past year and, with a number of vendors said to be up for sale, the trend is set to continue.

News in brief

CIT completed Lab Research takeover

28-Apr-2011 - French contract research organisation (CRO) CIT has completed its acquisition of Canadian counterpart Lab Research.

Mitsui to buy MBS to bolster CMO and strengthen in China

26-Apr-2011 - Mitsui is to boost its intermediate, API and finished product CMO business and expand in China by buying MBS.

Strategic deals to drive market share gains for big CROs

20-Apr-2011 - The top seven CROs will have captured half the market by 2015 as big pharma, including Pfizer, enters into strategic relationships with major players, Jeffries & Company said.

Round up of M&A in pharma contract services

19-Apr-2011 - Outsourcing-Pharma presents a round up of contract services merger and acquisition activity, including deals at Evotec, Vyteris and Avantium Pharma.

CIT to buy Canada’s LAB Research

13-Apr-2011 - French preclinical contract research organisation (CRO) CIT has said it will buy Canadian counterpart LAB Research in a deal that would rescue the Quebec-based firm from the receivers.

INC plans acquisitions to add scale, reach and capabilities

11-Apr-2011 - INC Research plans to make at least one acquisition over the next year as it expands scale, capabilities and geographic reach.

Imperial acquires D. Anderson & Company; expands clinical trial services

04-Apr-2011 - Michigan, US-based clinical research organisation (CRO), Imperial, has completed the acquisition of clinical trial specialists, D. Anderson & Company for an undisclosed fee.

Quintiles may look at takeovers and strategic deals

10-Mar-2011 - The US contract research organization (CRO) Quintiles may look at acquisitions and more ‘strategic partnerships’ after securing a $2.43bn credit facility.

Kendle committed to early stage, says incoming CEO

07-Mar-2011 - The incoming Kendle CEO has stressed commitment to early stage and said dramatic changes in the short- to medium-term are unlikely.

Clinipace buys regulatory affairs unit

02-Mar-2011 - Clinipace Worldwide has bought Regulus Pharmaceutical Consulting to add regulatory expertise to its eClinical contract research services business.

CMO consolidation will support 100% virtual supply chains

23-Feb-2011 - Consolidation of CMOs will support use of completely outsourced production and distribution networks in the near future.

News in brief

Numira Biosciences acquires Ricerca's Bothell lab operations

15-Feb-2011 - US-based Numira Biosciences has expanded its imaging and pre-clinical services portfolio after acquiring the efficacy pharmacology operating unit of Ricerca Biosciences.

QPS buys tox and preclinical testing capacity in Taiwan

14-Feb-2011 - QPS Holdings has acquired Taiwan’s Center of Toxicology and Preclinical Sciences (CTPS), continuing its expansion in the region’s rapidly expanding drug development sector.

Increasingly bold outsourcing will help big pharma cut costs

01-Feb-2011 - Big pharma outsourcing will become much bolder in the next 12-18 months as companies attempt to “dramatically attack cost structures”, according to the Covance CEO.

inVentiv to buy i3 & Campbell Alliance

24-Jan-2011 - inVentiv Health is to acquire i3 and Campbell Alliance and realign into three operating units: clinical, consulting and commercial.

CRI acquires Lifetree to expand Phase I capabilities

20-Jan-2011 - CRI Worldwide has acquired Lifetree Clinical Research to double its Phase I capacity and expand therapeutic expertise.

News in brief

Icon buys Oxford Outcomes to boost Ph IV biz

17-Jan-2011 - Dublin, Ireland-based contract research organisation (CRO) Icon has bought Oxford Outcomes, expanding its late Phase research business.

AMRI merges discovery units

10-Jan-2011 - AMRI has combined its discovery R&D and chemistry units into a single unit it claims will benefit customers.

Key Industry Events


Access all events listing

Our events, Shows & Conferences...